Supplemental material
Journal of Biomolecular Structure and Dynamics
Volume 39, 2021 - Issue 15
Research Articles
Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery
Mahmoud A. A. Ibrahima Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, EgyptCorrespondence[email protected]
https://orcid.org/0000-0003-4819-2040View further author information
https://orcid.org/0000-0003-4819-2040View further author information, , & Mohamed-Elamir F. Hegazyb Chemistry of Medicinal Plants Department, National Research Centre, El-Tahrir St, Dokki, Giza, Egypthttps://orcid.org/0000-0002-0343-4969View further author information
https://orcid.org/0000-0002-0343-4969View further author informationReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery
Source:
Taylor & Francis
Linking provided by
